|
TTC9C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6242562850266E-12 |
| Normal-vs-Stage2 |
3.0259000000088E-06 |
| Normal-vs-Stage3 |
7.69609999951015E-07 |
| Normal-vs-Stage4 |
1.53539999603325E-08 |
| Stage1-vs-Stage2 |
1.766400E-01 |
| Stage1-vs-Stage3 |
5.339100E-03 |
| Stage1-vs-Stage4 |
6.254800E-01 |
| Stage2-vs-Stage3 |
4.875600E-01 |
| Stage2-vs-Stage4 |
4.657400E-01 |
| Stage3-vs-Stage4 |
1.078160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.484800E-03 |
| Normal-vs-Asian |
8.683700E-02 |
| Caucasian-vs-AfricanAmerican |
1.021840E-02 |
| Caucasian-vs-Asian |
9.965600E-01 |
| AfricanAmerican-vs-Asian |
3.144400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
6.20614670765463E-14 |
| Male-vs-Female |
9.054800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.642630E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
8.06132938180326E-13 |
| Normal-vs-Age(81-100Yrs) |
2.834200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.562200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.670200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.886600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.105500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.219400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.129000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.224100E-04 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
3.72457620301248E-12 |
| Normal-vs-Grade 4 |
4.00720000000021E-05 |
| Grade 1-vs-Grade 2 |
1.736840E-01 |
| Grade 1-vs-Grade 3 |
9.104200E-02 |
| Grade 1-vs-Grade 4 |
7.673600E-02 |
| Grade 2-vs-Grade 3 |
1.375000E-01 |
| Grade 2-vs-Grade 4 |
1.139990E-01 |
| Grade 3-vs-Grade 4 |
5.323400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
9.90580000248542E-08 |
| ccA subtype-vs-ccB subtype |
2.70389999945664E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.50830475781549E-14 |
| Normal-vs-N1 |
1.363520E-02 |
| N0-vs-N1 |
5.695600E-01 |
|
|
